Device Technologies reaffirmed its commitment to reducing surgical material and packaging waste with Oertli Instruments’ portable cataract surgical device, CataRhex 3. While no confirmed figures are
Auckland-based Vision Rehabilitation Services (VRS) is a disability, low vision and blind rehabilitation service offering holistic and inclusive support. Building on a pro bono foundation, VRS is now a self-sufficient charity funded by grants and sponsors, said rehabilitation specialist and founder
The young progeny of a species of African fish have the visual edge on their parents when it comes to adaptation in murky waters, a recent study found.
This book’s name is somewhat of a misnomer – not only is it very enlightening on the subject of Asian blepharoplasty, it is also a very thoughtful and well laid out comprehensive text relevant to all blepharoplasty surgery. The author, William Chen, a clinical professor of ophthalmology at the Unive
A pledge to plant a native tree for every Rayner IOL used in New Zealand to reduce cataract surgery’s carbon footprint has exceeded expectations by nearly 60% in one year. The goal was 1,500 trees,
New study to build evidence for preservative-free glaucoma drops in NZ.
A registrar-led minor operations (MOPs) clinic designed to triage patients with suspected malignant ocular lesions diverted 90% of them away from ophthalmology theatres and reduced complication rates, reported study authors in a poster presented at the RANZCO NZ Branch meeting.
The second Women in Vision conference opens its doors to women in optometry and vision science.
US researchers reported that the 'Trojan horse' antibiotic cefiderocol was non-toxic and effective against a highly resistant strain of Pseudomonas aeruginosa in an experimental model of keratitis.
Rohto Mentholatum is the new Australasian distributor for Melcare’s Optimel manuka eye drops for dry eye, which will be distributed in New Zealand and Australia, together with Rohto’s Dry Aid lubrican
Using a novel type of optical coherence tomography (OCT) called polarisation-sensitive OCT (PS-OCT) a Japanese research team have identified scleral fibre patterns in highly myopic eyes which may help with the development of more targeted therapies for myopia.
A study looking at eyecare affordability in Australian collaborative clinics found one-quarter of patients are avoiding treatment for their eye conditions for cost reasons. The study, published
